Nephros Inc (NEPH)

Currency in USD
4.490
+0.590(+15.13%)
Closed·
4.4900.000(0.00%)
·
NEPH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
NEPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.9504.896
52 wk Range
1.3645.000
Key Statistics
Prev. Close
3.9
Open
3.95
Day's Range
3.95-4.896
52 wk Range
1.364-5
Volume
138.4K
Average Volume (3m)
44.15K
1-Year Change
98.98%
Book Value / Share
0.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.500
Upside
+22.49%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Nephros Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Nephros Inc Company Profile

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nephros Inc Earnings Call Summary for Q2/2025

  • Nephros Inc. reported Q2 2025 revenue of $4.4M, a 36% YoY increase, with EPS of $0.02 beating -$0.01 forecast
  • Net income turned positive at $237,000, reversing previous year's loss; gross margins improved to 63% from 59% in Q2 2024
  • Despite strong results, stock fell 3.67% in after-hours trading to $2.89; company maintains strong financial health
  • Forward guidance: Q3 2025 EPS -$0.02, revenue $3.75M; Q4 2025 EPS -$0.01, revenue $3.86M
  • CEO emphasized growth in underserved verticals and regional outperformance; company plans continued sales force expansion
Last Updated: 08/08/2025, 10:48
Read Full Transcript

Compare NEPH to Peers and Sector

Metrics to compare
NEPH
Peers
Sector
Relationship
P/E Ratio
31.2x15.6x12.7x
PEG Ratio
0.160.000.03
Price/Book
4.3x1.0x1.4x
Price / LTM Sales
2.5x0.5x1.2x
Upside (Analyst Target)
41.0%30.0%15.8%
Fair Value Upside
Unlock23.1%6.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.500
(+22.49% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.02 / -0.01
Revenue / Forecast
4.40M / 3.60M
EPS Revisions
Last 90 days

NEPH Income Statement

People Also Watch

6.860
TRON
-1.58%
1.72
CTOR
-4.97%
3.210
IMRX
-1.23%
0.620
VNRX
-3.43%
72.69
MP
-2.19%

FAQ

What Stock Exchange Does Nephros Trade On?

Nephros is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Nephros?

The stock symbol for Nephros is "NEPH."

What Is the Nephros Market Cap?

As of today, Nephros market cap is 47.91M.

What Is Nephros's Earnings Per Share (TTM)?

The Nephros EPS (TTM) is 0.13.

When Is the Next Nephros Earnings Date?

Nephros will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is NEPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nephros Stock Split?

Nephros has split 2 times.

How Many Employees Does Nephros Have?

Nephros has 31 employees.

What is the current trading status of Nephros (NEPH)?

As of 11 Aug 2025, Nephros (NEPH) is trading at a price of 4.49, with a previous close of 3.90. The stock has fluctuated within a day range of 3.95 to 4.90, while its 52-week range spans from 1.36 to 5.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.